BARDA Nonclinical Development Biological Network
Closed Solicitation Posted
This opportunity was awarded. See its 6 award notices in the notice history.
- Solicitation number
- 75A50122R00008
- Agency
- Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Biomedical Advanced Research and Development Authority seeks to establish a Nonclinical Services Network through multiple Indefinite Delivery/Indefinite Quantity contracts to provide expertise, capacity, and program management across three capability areas: animal model development and medical countermeasure testing for biological agents; analytical method development and validation testing; and safety and toxicity testing. BARDA intends to award IDIQ contracts with a minimum $75,000 guarantee to organizations or consortiums demonstrating through responses to sample task orders that they meet the qualifications for capability areas 1, 2 or 3. Proposals are due by May 20, 2022 and will be evaluated based on the responses to the sample task orders.
There is no set-aside designation for this solicitation. The primary NAICS code is 541715 and PSC code is R425. BARDA anticipates awarding contracts of indefinite quantity and duration that will be administered and used to support BARDA initiatives requiring nonclinical services to help accomplish its mission of developing medical countermeasures against threats like CBRN accidents, pandemics and emerging diseases. The place of performance will be within the United States.
Notice text
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.
Together with our industry partners, BARDA promotes the advanced development of medical countermeasures (MCM) to protect Americans and respond to 21st century health security threats.
The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) MCM Review (2010) recommended that PHEMCE partners provide not only financial help to medical countermeasure developers but also technical and regulatory assistance. BARDA’s Strategic Plan (2011) set a goal to provide assistance to developers through core assistance programs in critical areas including nonclinical and clinical services to obtain safety and efficacy data supporting MCM development.
To meet the demands for MCM development and support an ever-increasing need for nonclinical services including those required to address 21st Century Threats and BARDA’s innovation activities, this solicitation seeks to establish a Nonclinical Services Network of laboratories providing expertise, capacity, and program management across three capability areas:
Capability Area 1: Animal Model Development and MCM Testing (Biological Agents)
Capability Area 2: Analytical Method Development, Qualification, Validation, and Testing
Capability Area 3: Safety and Toxicity Testing
BARDA anticipates awarding multiple IDIQ contracts that provide a guaranteed minimum award to the organizations or consortiums that meet the overall qualifications needed to fulfill the technical requirements of this solicitation for each capability area. Sample Task Orders are provided in the RFP solely to evaluate Offerors’ responses and capabilities. Responses for Task Order Requests (RTORs) for specific tasks will be issued after award of the Parent Contract. This IDIQ will be administered and used to support BARDA initiatives as necessary to help accomplish its mission.
Attachments
| File | Type | Posted |
|---|---|---|
| BARDA RFP 75A50122R00008_FINAL_(Amendment 3) Final.pdf | ||
| BARDA RFP 75A50122R00008_FINAL_(Amendment 2) signed.pdf | ||
| BARDA RFP 75A50122R00008 Final_Amendment 1.pdf | ||
| BARDA RFP 75A50122R00008_FINAL_(signed).pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| BARDA Nonclinical Development Biological Network | Award Notice | |
| BARDA Nonclinical Development Biological Network | Award Notice | |
| BARDA Nonclinical Development Biological Network | Award Notice | |
| BARDA Nonclinical Development Biological Network | Solicitation | |
| BARDA Biological Animal Model and MCM Development | Pre-Solicitation | |
| BARDA Biological Animal Model and MCM Development | Pre-Solicitation |
And 3 more award notices.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity